Restricted accessCase reportFirst published online 2014-03
A Teenaged Patient with Severe Asparaginase-Induced Hypertriglyceridemia Safely Re-Challenged During Primary and Relapse Therapy for Acute Lymphoblastic Leukemia
Asparaginase is a highly effective drug in the management of acute lymphoblastic leukemia (ALL), but can cause abnormalities in lipid metabolism leading to hypercholesterolemia and hypertriglyceridemia. This may result in serious consequences, such as pancreatitis and hyperviscosity syndrome. Currently, there is no consensus regarding re-challenge with further doses of asparaginase if this complication occurs. We report the case of a teenaged male patient with ALL treated with asparaginase who presented with extreme hyperlipidemia during induction therapy. He was managed conservatively with complete resolution of lipid abnormalities and was re-challenged during both primary and relapse therapy without a recurrence of hyperlipidemia.
OhnumaT, HollandJF, FreemanA, SinksLF. Biochemical and pharmacological studies with asparaginase in man. Cancer Res., 1970; 30(9):2297–305.
3.
RidolaV, BuonuomoPS, MauriziP, et al.Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis. Pediatr Blood Cancer., 2008; 50(2):378–80.
4.
SallanSE, Hitchcock-BryanS, GelberR, et al.Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res., 1983; 43(11):5601–7.
5.
CohenH, BieloraiB, HaratsD, et al.Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Pediatr Blood Cancer., 2010; 54(5):703–6.
6.
ParsonsSK, SkapekSX, NeufeldEJ, et al.Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood., 1997; 89(6):1886–95.
7.
SinghT, SatheeshCT, MadhumathiDS, et al.Turbid serum in a patient of acute lymphoblastic leukemia on treatment—what to look for?. J Cancer Res Ther., 2009; 5(3):219–20.
8.
SteinherzPG. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer., 1994; 74(12):3234–9.
9.
HoogerbruggeN, JansenH, HoogerbruggePM. Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity. Leukemia., 1997; 11(8):1377–9.
10.
PietersR, HungerSP, BoosJ, et al.L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer., 2011; 117(2):238–49.
11.
LashkariHP, LancasterD, AtraA, et al.Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?. Int J Hematol., 2011; 94(6):571–5.
12.
LohML, HarveyRC, MullighanCG, et al.A BCR-ABL1-like gene expression profile confers a poor prognosis in patients with high-risk acute lymphoblastic leukemia (HR-ALL): a report from Children's Oncology Group (COG) AALL0232. Blood., 2011; 118(21):abstract 743.
13.
Zalewska-SzewczykB, MatusiakI, WykaK, et al.Changes in the lipid profile in children with acute lymphoblastic leukaemia—the influence of the disease and its treatment. Med Wieku Rozwoj., 2008; 12(4 Pt 2):1035–40. [article in Polish]
YuanG, Al-ShaliKZ, HegeleRA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ., 2007; 176(8):1113–20.
16.
OhRC, LanierJB. Management of hypertriglyceridemia. Am Fam Physician., 2007; 75(9):1365–71.
17.
AbourbihS, FilionKB, JosephL, et al.Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am J Med., 2009; 122(10):962.e1–8
18.
ShearerGC, SavinovaOV, HarrisWS. Fish oil—how does it reduce plasma triglycerides?. Biochim Biophys Acta., 2012; 1821(5):843–51.
19.
BostromB. Successful management of extreme hypertriglyceridemia from pegaspargase with omega-3. Pediatr Blood Cancer., 2012; 59(2):350.
20.
Solano-PáezP, VillegasJA, ColomerI, et al.L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia. J Pediatr Hematol Oncol., 2011; 33(3):e122–4.
21.
Kfoury-BazEM, NassarRA, TaniosRF, et al.Plasmapheresis in asparaginase-induced hypertriglyceridemia. Transfusion., 2008; 48(6):1227–30.
22.
YehJH, LeeMF, ChiuHC. Plasmapheresis for severe lipemia: comparison of serum-lipid clearance rates for the plasma-exchange and double-filtration variants. J Clin Apher., 2003; 18(1):32–6.
23.
TongWH, PietersR, van der SluisIM. Successful management of extreme hypertriglyceridemia in a child with acute lymphoblastic leukemia by temporarily omitting dexamethasone while continuing asparaginase. Pediatr Blood Cancer., 2012; 58(2):317–8.
24.
SalvadorC, MeisterB, CrazzolaraR, KropshoferG. Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy. Pediatr Blood Cancer., 2012; 59(4):771.
